SEARCH

SEARCH BY CITATION

References

  • 1
    O'Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004; 14: 23-26.
  • 2
    Hiestand DM, Britz P, Goldman M, et al. Prevalence of symptoms and risk of sleep apnea in the us population: results from the national sleep foundation sleep in America 2005 poll. Chest 2006; 130: 780-786.
  • 3
    Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001; 163: 19-25.
  • 4
    Visser M, Bouter LM, McQuillan GM, et al. Elevated c-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
  • 5
    Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316.
  • 6
    Kataoka T, Enomoto F, Kim R, et al. The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma tnf-alpha levels. Tohoku J Exp Med 2004; 204: 267-272.
  • 7
    Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007; 30: 29-34.
  • 8
    Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8: 941-946.
  • 9
    Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004; 95: 1140-1153.
  • 10
    Krieger J, Grucker D, Sforza E, et al. Left ventricular ejection fraction in obstructive sleep apnea. Effects of long-term treatment with nasal continuous positive airway pressure. Chest 1991; 100: 917-921.
  • 11
    Peiser J, Ovnat A, Uwyyed K, et al. Cardiac arrhythmias during sleep in morbidly obese sleep-apneic patients before and after gastric bypass surgery. Clin Cardiol 1985; 8: 519-521.
  • 12
    Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-3021.
  • 13
    Guardiano SA, Scott JA, Ware JC, et al. The long-term results of gastric bypass on indexes of sleep apnea. Chest 2003; 124: 1615-1619.
  • 14
    Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042-1047.
  • 15
    Karason K, Wallentin I, Larsson B, et al. Effects of obesity and weight loss on cardiac function and valvular performance. Obes Res. 1998; 6: 422-429.
  • 16
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
  • 17
    Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009; 122: 535-542.
  • 18
    Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
  • 19
    Sjostrom L, Larsson B, Backman L, et al. Swedish obese subjects (sos). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992; 16: 465-479.
  • 20
    Gislason T, Almqvist M, Eriksson G, et al. Prevalence of sleep apnea syndrome among Swedish men—an epidemiological study. J Clin Epidemiol 1988; 41: 571-576.
  • 21
    Marshall NS, Delling L, Grunstein RR, et al. Self-reported sleep apnoea and mortality in patients from the Swedish obese subjects study. Eur Respir J 2011; 38: 1349-1354.
  • 22
    Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda, MD.: U.S. Dept. of Health, Education, and Welfare; 1968.
  • 23
    Iber C, American Academy of Sleep Medicine. The aasm manual for the scoring of sleep and associated events: Rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
  • 24
    Gooneratne NS, Richards KC, Joffe M, et al. Sleep disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults. Sleep 2011; 34: 435-442.
  • 25
    Sredniawa B, Lenarczyk R, Kowalski O, et al. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace 2009; 11: 106-114.
  • 26
    Yoneyama K, Osada N, Shimozato T, et al. Relationship between sleep-disordered breathing level and acute onset time of congestive heart failure. Int Heart J 2008; 49: 471-480.
  • 27
    Byrd BF III, Finkbeiner W, Bouchard A, et al. Accuracy and reproducibility of clinically acquired two-dimensional echocardiographic mass measurements. Am Heart J 1989; 118: 133-137.
  • 28
    Starling MR, Crawford MH, Sorensen SG, et al. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Circulation 1981; 63: 1075-1084.
  • 29
    Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton health study. Sleep 2008; 31: 1079-1085.
  • 30
    Sjostrom CD, Peltonen M, Wedel H, et al. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20-25.
  • 31
    Grunstein RR, Stenlof K, Hedner JA, et al. Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep 2007; 30: 703-710.
  • 32
    Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143.
  • 33
    McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178
  • 34
    Vgontzas AN, Zoumakis M, Papanicolaou DA, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002; 51: 887-892.
  • 35
    Mehra R, Storfer-Isser A, Kirchner HL, et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 2006; 166: 1725-1731.
  • 36
    Taheri S, Austin D, Lin L, et al. Correlates of serum c-reactive protein (crp)—no association with sleep duration or sleep disordered breathing. Sleep 2007; 30: 991-996.
  • 37
    Sharma SK, Mishra HK, Sharma H, et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-crp levels in patients with sleep-disordered breathing in Delhi. Sleep Med 2008; 9: 149-156.
  • 38
    Otto ME, Belohlavek M, Romero-Corral A, et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007; 99: 1298-1302.
  • 39
    Tanriverdi H, Evrengul H, Kaftan A, et al. Effect of obstructive sleep apnea on aortic elastic parameters: relationship to left ventricular mass and function. Circ J 2006; 70: 737-743.
  • 40
    Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112: 375-383.